Compound ID	CDAMM02876
Common name	Spongipregnoloside D
IUPAC name	1-[3-[4-hydroxy-6-(hydroxymethyl)-3,5-bis[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy-16-methoxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
Molecular formula	C₄₀H₆₄O₁₆

Experimental data

Retention time	13.56
Adduct	[M+H]+
Actual mz	801.418
Theoretical mz	801.426
Error	10.2
Ionizaton mode	Positive
Instrument type	LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score	5.8818

Identifiers and class information

Inchi key	OVNISBFHKJPJTA-PMFADJDVNA-N
Smiles	O=C(C)C1C(OC)CC2C3CC=C4CC(OC5OC(CO)C(OC6OC(C)C(O)C(O)C6O)C(O)C5OC7OC(C)C(O)C(O)C7O)CCC4(C)C3CCC12C
Superclass	Lipids and lipid-like molecules
Class	Steroids and steroid derivatives

Plant source

Convolvulus prostratus Forssk.

External sources

HMDB ID
KNApSAcK ID	C00032192
FooDB ID
DrugBank ID
ChEBI ID
Pubchem Compound ID	162933163
PlantCyc ID
UNPD ID	UNPD162509
Coconut ID	CNP0203188
LipidMAPS ID	LMST02030220
NANPDB ID

Pharmacokinetic properties

Number of descriptor values(#stars)	11
Number of non-conjugated amine groups (#amine)	0
Number of amidine and guanidine groups (#amidine)	0
Number of carboxylic acid groups (#acid)	0
Number of non-conjugated amide groups (#amide)	0
Number of rotatable bonds (#rotor)	17
Number of reactive functional groups (#rtvFG)	4
Predicted central nervous system activity (CNS)	-2
Molecular weight (mol_MW)	800.936
Computed dipole moment(dipole)	6.739
Total solvent accessible surface area (SASA)	1002.38
Hydrophobic component of SASA (FOSA)	696.681
Hydrophilic component of SASA (FISA)	282.334
Pie component of the SASA (PISA)	23.362
Weakly polar component of the SASA (WPSA)	0
Total solvent accesible volume (volume)	2147.88
Number of hydrogen bond donors (donorHB)	8
Number of hydrogen bond acceptors (accptHB)	27.5
Free energy of solvation of dipole (dip^2/V)	0.021142
Index of cohesive interaction in solids (ACxDN^.5/SA)	0.0775973
Globularity descriptor (glob)	0.803171
Predicted polarizability in cubic angstroms (QPpolrz)	69.112
Predicted hexadecane/gas partition coefficient (QPlogPC16)	21.547
Predicted octanol/gas partition coefficient (QPlogPoct)	50.481
Predicted water/gas partition coefficient (QPlogPw)	39.265
Predicted octanol/water partition coefficient (QPlogPo/w)	-0.968
Predicted aqueous solubility (QPlogS)	-2.589
Conformation-independent predicted aqueous solubility (CIQPlogS)	-4.216
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)	-4.828
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)	20.822
Predicted brain/blood partition coefficient (QPlogBB)	-3.379
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)	7.531
Predicted skin permeability, log Kp (QPlogKp)	-5.008
PM3 calculated ionization potential (IP(ev))	9.35
PM3 calculated electron affinity (EA(eV))	-0.741
Number of likely metabolic reactions (#metab)	11
Prediction of binding to human serum albumin (QPlogKhsa)	-1.337
Predicted qualitative human oral absorption (HumanOralAbsorption)	1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)	6
Solvent-accessible surface area of fluorine atoms (SAFluorine)	0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)	0
Van der Waals surface area (PSA)	233.226
Number of nitrogen and oxygen atoms (#NandO)	16
Number of violations of Lipinski’s rule of five (RuleOfFive)	3
Number of violations of Jorgensen’s rule of three (RuleOfThree)	2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID	Gene name	Target name	TTD_ID	Prediction source
Q15125	EBP	Anti-estrogen binding site (AEBS)	T25317	SEA
P31213	SRD5A2	Steroid 5-alpha-reductase 2	T71390	SEA
P08185	SERPINA6	Corticosteroid binding globulin	T88452	SEA
Q9UHC9	NPC1L1	Niemann-Pick C1-like protein 1	T33901	SEA
Q13133	NR1H3	LXR-alpha	T52297	SEA
P11413	G6PD	Glucose-6-phosphate 1-dehydrogenase	T63484	SEA
P05093	CYP17A1	Cytochrome P450 17A1	T89041	SEA
P60568	IL2	Interleukin-2	T61698	SEA
P17931	LGALS3	Galectin-3	T72038	SEA
P04746	AMY2A	Pancreatic alpha-amylase	T86918	SEA
Q99417	MYCBP	MYCBP messenger RNA	T37298	SEA
O15439	ABCC4	Multidrug resistance protein 4	T39919	SEA

Target associated diseases

TTD_ID	Disease_ID	Disease name	ICD_11	Uniprot ID	Gene names
T25317	DI0366	Rheumatoid arthritis	[ICD-11: FA20]	Q15125	EBP
T71390	DI0348	Prostate hyperplasia	[ICD-11: GA90]	P31213	SRD5A2
T88452	DI0037	Asthma	[ICD-11: CA23]	P08185	SERPINA6
T88452	DI0339	Postoperative inflammation	[ICD-11: 1A00-CA43]	P08185	SERPINA6
T88452	DI0362	Respiratory system disease	[ICD-11: CB40-CB7Z]	P08185	SERPINA6
T33901	DI0188	Hyper-lipoproteinaemia	[ICD-11: 5C80]	Q9UHC9	NPC1L1
T52297	DI0117	Depression	[ICD-11: 6A70-6A7Z]	Q13133	NR1H3
T63484	DI0086	Chronic obstructive pulmonary disease	[ICD-11: CA22]	P11413	G6PD
T89041	DI0346	Prostate cancer	[ICD-11: 2C82]	P05093	CYP17A1
T61698	DI0275	Multiple sclerosis	[ICD-11: 8A40]	P60568	IL2
T61698	DI0361	Renal cell carcinoma	[ICD-11: 2C90]	P60568	IL2
T72038	DI0190	Hypertension	[ICD-11: BA00-BA04]	P17931	LGALS3
T72038	DI0199	Idiopathic interstitial pneumonitis	[ICD-11: CB03]	P17931	LGALS3
T72038	DI0252	Melanoma	[ICD-11: 2C30]	P17931	LGALS3
T72038	DI0302	Non-alcoholic fatty liver disease	[ICD-11: DB92]	P17931	LGALS3
T72038	DI0351	Psoriasis	[ICD-11: EA90]	P17931	LGALS3
T86918	DI0110	Cystic fibrosis	[ICD-11: CA25]	P04746	AMY2A
T86918	DI0328	Pancreatic malfunction	[ICD-11: DC30-DC3Z]	P04746	AMY2A
T37298	DI0235	Liver cancer	[ICD-11: 2C12]	Q99417	MYCBP